Results 21 to 30 of about 24,956 (275)

BET–HDAC Dual Inhibitors for Combinational Treatment of Breast Cancer and Concurrent Candidiasis

open access: yes, 2023
Breast cancer is susceptible to Candida infections, and candidiasis has an enhancing effect on the progression and metastasis of tumor. Breast cancer and concurrent candidiasis represent a significant challenge in clinical therapy.
Chunquan Sheng (1364184)   +4 more
core   +6 more sources

Methylpyrrole inhibitors of BET bromodomains [PDF]

open access: yesBioorganic & Medicinal Chemistry Letters, 2017
An NMR fragment screen for binders to the bromodomains of BRD4 identified 2-methyl-3-ketopyrroles 1 and 2. Elaboration of these fragments guided by structure-based design provided lead molecules with significant activity in a mouse tumor model. Further modifications to the methylpyrrole core provided compounds with improved properties and enhanced ...
Lisa A, Hasvold   +27 more
openaire   +2 more sources

Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity

open access: yes, 2022
Bromodomain and extraterminal domain (BET) proteins are important regulators of gene transcription and chromatin remodeling. BET family members BRD4 and BRDT are validated targets for cancer and male contraceptive drug development, respectively.
Narsihmulu Cheryala (13141368)   +7 more
core   +3 more sources

Design and characterization of bivalent BET inhibitors [PDF]

open access: yesNature Chemical Biology, 2016
Cellular signaling is often propagated by multivalent interactions. Multivalency creates avidity, allowing stable biophysical recognition. Multivalency is an attractive strategy for achieving potent binding to protein targets, as the affinity of bivalent ligands is often greater than the sum of monovalent affinities.
Tanaka, Minoru   +8 more
openaire   +4 more sources

BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma

open access: yesEpigenetics, 2021
(1) Background: BET bromodomain proteins regulate transcription by binding acetylated histones and attracting key factors for, e.g., transcriptional elongation.
Elisa Funck-Brentano   +3 more
doaj   +1 more source

Chiral Analogues of PFI-1 as BET Inhibitors and Their Functional Role in Myeloid Malignancies [PDF]

open access: yesACS Medicinal Chemistry Letters, 2020
Marcus Frings   +2 more
exaly   +2 more sources

A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles

open access: yesFrontiers in Pharmacology, 2022
Epigenetic modifications, specifically acetylation of histone plays a decisive role in gene regulation and transcription of normal cellular mechanisms and pathological conditions.
Hafiz Akbar Ali   +7 more
doaj   +1 more source

Inhibition of BET Family Proteins Suppresses African Swine Fever Virus Infection

open access: yesMicrobiology Spectrum, 2022
African swine fever (ASF), an acute, severe, highly contagious disease caused by African swine fever virus (ASFV) infection in domestic pigs and boars, has a mortality rate of up to 100%.
Yaru Zhao   +13 more
doaj   +1 more source

Roles of Bromodomain Extra Terminal Proteins in Metabolic Signaling and Diseases

open access: yesPharmaceuticals, 2022
BET proteins, which recognize and bind to acetylated histones, play a key role in transcriptional regulation. The development of chemical BET inhibitors in 2010 greatly facilitated the study of these proteins.
Dayu Wu, Qiong Duan
doaj   +1 more source

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction

open access: yesNature Communications, 2020
Inhibitors of the BET family proteins are limited by their potency and oral bio-availability. Here, the authors report a new BET inhibitor, NHWD-870, with improved potency compared to previous BET inhibitors, and show that it suppresses BRD4 and targets ...
Mingzhu Yin   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy